HealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.38, $0.04 better than the analyst estimate of $0.34. Revenue for the quarter came in at $216.1 million versus the consensus estimate of $206.75 million.

GUIDANCE:

HealthEquity sees Q4 2023 EPS of $1.26-$1.35, versus the consensus of $1.27. HealthEquity sees Q4 2023 revenue of $850-860 million, versus the consensus of $839.5 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.